BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia
- 9 December 2002
- journal article
- review article
- Published by Springer Nature in Oncogene
- Vol. 21 (56) , 8547-8559
- https://doi.org/10.1038/sj.onc.1206082
Abstract
No abstract availableKeywords
This publication has 196 references indexed in Scilit:
- Evolution of bone marrow transplantation – the original immunotherapyTrends in Immunology, 2001
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Inhibition of Grb2 and Crkl Proteins Results in Growth Inhibition of Philadelphia Chromosome Positive Leukemic CellsBiochemical and Biophysical Research Communications, 1997
- Regulation of Bcl-2 gene expression by BCR-ABL is mediated by RasJournal of Molecular Biology, 1997
- Lactacystin, a Specific Inhibitor of the Proteasome, Induces Apoptosis in Human Monoblast U937 CellsBiochemical and Biophysical Research Communications, 1995
- Structure-function relationships of hammerhead ribozymes: from understanding to applicationsTrends in Biotechnology, 1995
- Cleavage of BCR/ABL mRNA by Synthetic Ribozymes - Effects on the Proliferation Rate of K562 CellsKlinische Padiatrie, 1995
- Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAsFEBS Letters, 1994
- Generation of Donor-Derived Antileukemic Cytotoxic T-Lymphocyte Responses for Treatment of Relapsed Leukemia After Allogeneic HLA-Identical Bone Marrow TransplantationJournal of Immunotherapy, 1993
- Les agriculteurs sarthois dans les conseils municipauxNorois, 1977